EpMab-16の論文がOncology reportsに掲載されました。
https://www.spandidos-publications.com/10.3892/or.2020.7808
Kaneko MK, Ohishi T, Takei J, Sano M, Nakamura T, Hosono H, Yanaka M, Asano T, Sayama Y, Harada H, Kawada M, Kato Y.*
(*corresponding author)
The Anti-EpCAM monoclonal antibody (EpMab-16) exerts anti-tumor activity against oral squamous cell carcinomas
Oncology Reports., https://doi.org/10.3892/or.2020.7808, 2020 (PDF)